Biovail Appoints Dr. Neil M. Sussman Vice-President, Neurologic & Psychiatric Development.TORONTO -- Biovail Corporation (NYSE NYSE See: New York Stock Exchange :BVF)(TSX:BVF) today announced the appointment of Dr. Neil M. Sussman as Vice-President, Neurologic and Psychiatric Development of Biovail Technologies, Ltd. The appointment is effective immediately. Dr. Sussman brings a wealth of business and academic experience in the field of neurology and other central nervous system (CNS See Continuous net settlement. CNS See continuous net settlement (CNS). ) disorders to Biovail. "We are delighted to have an individual as qualified as Dr. Sussman join our Medical and Scientific Affairs team," said Bill Wells, Biovail's Chief Executive Officer. "The addition of his expertise and experience in CNS disorders is an important step in the implementation of Biovail's New Strategic Focus." Prior to joining Biovail, Dr. Sussman was President of NMSNeuro Consulting, specializing in therapeutic areas such as dementia, mania, neuroprotection, multiple sclerosis and Parkinson's disease. Before that, Dr. Sussman was Senior Director, CNS Clinical Research of Kyowa Pharmaceutical, overseeing development-stage products in Parkinson's disease. Earlier in his career, Dr. Sussman held positions of increasing responsibly at Marion Merrell Dow where he worked on the development of vigabatrin (Sabril); Abbott Laboratories, where he served as Venture Head, Neurotherapeutics; Bristol-Myers Squibb's CNS Clinical Research division; and Forest Laboratories, as Director, CNS Clinical Development, where he was involved in the development of escitalopram (Lexapro). He also spent four years as Director, Medical Affairs with PRA International, a global clinical research (CRO) organization. Dr. Sussman received his medical training at New York Medical College New York Medical College is a center for graduate medical education located in Westchester County, a suburb half an hour north of New York City. This private university comprises the School of Medicine, which grants the M.D. and completed his Neurology Residency at Thomas Jefferson University It began as Jefferson Medical College in 1824. On July 1, 1969 the institution officially became Thomas Jefferson University. The university is made up of three colleges:
http://upenn.edu/. Address: Philadelphia, PA, USA. , Medical College of Pennsylvania Medical College of Pennsylvania, formerly in Philadelphia; chartered and opened 1850 as the Female Medical College of Pennsylvania; became Woman's Medical College of Pennsylvania 1867, Medical College of Pennsylvania 1970. and Yale University School of Medicine, and he is a Fellow in the American Academy of Neurology The American Academy of Neurology (AAN) is a professional society for neurologists and neuroscientists. As a medical specialty society it was established in 1949 by A.B. Baker of the University of Minnesota to advance the art and science of neurology, and thereby promote the best . Dr. Sussman has co-authored over 30 peer-reviewed original papers in the area of CNS disorders. His knowledge, energy and extensive network should facilitate Biovail's future drug-development success. About Biovail Corporation Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company's Web site at www.biovail.com. For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to ir@biovail.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion